Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision changed from v3.8.0 to v3.8.1, with no visible change to the study record.
    Difference
    0.1%
    Check dated 2026-11-18T01:14:08.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The NIVES clinical-trial record for nivolumab combined with stereotactic radiotherapy in metastatic renal cell carcinoma is displayed, including its completed status and study design. It also provides participant eligibility, treatment details, outcome measures, locations, and investigators.
    Difference
    43%
    Check dated 2026-11-10T20:37:50.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T20:40:13.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the ClinicalTrials.gov page, and the site revision changes from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T20:56:30.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:51:09.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error replacing the study record content, with a standard site header/footer and no trial details visible.
    Difference
    17%
    Check dated 2026-09-22T22:06:46.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.